Form 4: Airsculpt Technologies Director and 10% Owner Boosts Stake with $4 Million Stock Purchase
Insider Transaction Report
Adam T. Feinstein, a Director and 10% owner of Airsculpt Technologies, Inc., along with affiliated entities, acquired 1,000,000 shares of common stock for $4 million.
Summary
- Adam T. Feinstein, a Director and 10% Owner of Airsculpt Technologies, Inc. (AIRS), reported significant purchases of the company's common stock.
- On June 9, 2025, a total of 1,000,000 shares of Common Stock, $0.001 Par Value, were acquired across three indirect transactions.
- The shares were purchased at a price of $4.00 per share, totaling $4,000,000 in investment.
- The acquisitions were made indirectly through VSCP EBS Aggregator, L.P. (462,957 shares), Vesey Street Capital Partners Healthcare Fund-A, LP (149,185 shares), and EBS Aggregator Blocker Holdings, LLC (387,858 shares).
- Following these transactions, the beneficial ownership stands at 14,038,819 shares for VSCP EBS Aggregator, L.P., 4,523,899 shares for Vesey Street Capital Partners Healthcare Fund-A, LP, and 11,761,462 shares for EBS Aggregator Blocker Holdings, LLC, totaling 30,324,180 shares indirectly owned by Adam T. Feinstein and affiliated entities.
Sentiment
Score: 9
Explanation: The sentiment is highly positive due to a substantial insider purchase by a director and 10% owner, indicating strong confidence in the company's valuation and future prospects.
Positives
- Significant insider buying by a Director and 10% owner signals strong confidence in the company's future prospects and valuation.
- The substantial investment of $4 million by key insiders demonstrates a belief that the stock is undervalued at the current price of $4 per share.
- Increased insider ownership aligns the interests of management and major shareholders with those of public investors, potentially leading to more shareholder-friendly decisions.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance.
Industry Context
Insider purchases, especially of this magnitude, can be interpreted by the market as a strong vote of confidence in the company's future performance and strategic direction, potentially indicating that insiders believe the stock is undervalued relative to its intrinsic worth or future growth prospects within the medical aesthetics industry.
Related Party Transactions
- The reported transactions involve Adam T. Feinstein, a Director and 10% owner, and entities (VSCP EBS Aggregator, L.P., Vesey Street Capital Partners Healthcare Fund-A, LP, and EBS Aggregator Blocker Holdings, LLC) through which he indirectly holds beneficial ownership, classifying these as related party transactions.
Stakeholder Impact
- Shareholders: The significant insider buying could instill greater confidence among existing and potential shareholders, potentially leading to increased investor interest and a positive impact on share price.
- Management: The purchases reinforce the alignment of interests between the company's leadership and its shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/09/2025 | Date of common stock acquisition transactions. |
| 06/11/2025 | Date the Form 4 filing was signed and submitted. |
Recommendation
strong buyKeywords
Airsculpt Technologies, AIRS, Insider Buying, Form 4, Stock Purchase, Beneficial Ownership, Director, 10% Owner, Vesey Street Capital Partners
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.